A Comparison of Current Guidelines of Five International Societies on Clostridium difficile Infection Management

被引：33
作者：
Fehér C. [1 ]
Mensa J. [1 ]
机构：
[1] Department of Infectious Diseases, Hospital Clínic of Barcelona, C/Villarroel 170, Barcelona
来源：
Infectious Diseases and Therapy | 2016年 / 5卷 / 3期
关键词：
CDI recurrence risk; CDI severity; Clostridium difficile infection (CDI); Contact isolation precautions; International guidelines;
D O I：
10.1007/s40121-016-0122-1
中图分类号：
学科分类号：
摘要：
Clostridium difficile infection (CDI) is increasingly recognized as an emerging healthcare problem of elevated importance. Prevention and treatment strategies are constantly evolving along with the apperance of new scientific evidence and novel treatment methods, which is well-reflected in the differences among consecutive international guidelines. In this article, we summarize and compare current guidelines of five international medical societies on CDI management, and discuss some of the controversial and currently unresolved aspects which should be addressed by future research. © 2016, The Author(s).
引用
收藏
页码：207 / 230
页数：23
相关论文
共 113 条
  • [41] Polage C.R., Gyorke C.E., Kennedy M.A., Et al., Overdiagnosis of Clostridium difficile infection in the molecular test era, JAMA Intern Med, 175, pp. 1792-1801, (2015)
  • [42] Chakra C.N.A., Pepin J., Sirard S., Valiquette L., Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review, PLoS ONE, 9, (2014)
  • [43] Bauer M.P., Notermans D.W., van Benthem B.H., Et al., Clostridium difficile infection in Europe: a hospital-based survey, Lancet, 377, pp. 63-73, (2011)
  • [44] Henrich T.J., Krakower D., Bitton A., Yokoe D.S., Clinical risk factors for severe Clostridium difficile-associated disease, Emerg Infect Dis, 15, pp. 415-422, (2009)
  • [45] Morrison R.H., Hall N.S., Said M., Et al., Risk factors associated with complications and mortality in patients with Clostridium difficile infection, Clin Infect Dis, 53, pp. 1173-1178, (2011)
  • [46] Zilberberg M.D., Shorr A.F., Micek S.T., Doherty J.A., Kollef M.H., Clostridium difficile-associated disease and mortality among the elderly critically ill, Crit Care Med, 37, pp. 2583-2589, (2009)
  • [47] Welfare M.R., Lalayiannis L.C., Martin K.E., Corbett S., Marshall B., Sarma J.B., Co-morbidities as predictors of mortality in Clostridium difficile infection and derivation of the ARC predictive score, J Hosp Infect, 79, pp. 359-363, (2011)
  • [48] Bhangu S., Bhangu A., Nightingale P., Michael A., Mortality and risk stratification in patients with Clostridium difficile-associated diarrhoea, Color Dis, 12, pp. 241-246, (2010)
  • [49] Marra A.R., Edmond M.B., Wenzel R.P., Bearman G.M.L., Hospital-acquired Clostridium difficile-associated disease in the intensive care unit setting: epidemiology, clinical course and outcome, BMC Infect Dis, 7, (2007)
  • [50] Gravel D., Miller M., Simor A., Et al., Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian nosocomial infection surveillance program study, Clin Infect Dis, 48, pp. 568-576, (2009)
12345678910